Clinical trial
Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients…
NCT00425425 · Technical University of Munich, Other · Unknown status
Key facts
| NCT number | NCT00425425 |
|---|---|
| Title | Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer |
| Official title | Neoadjuvant Radiochemotherapy in Local Advanced Squamous Cell Carcinoma of the Esophagus With Weekly Cetuximab Plus Oxaliplatin Plus Continuous IV. 5-FU and Conventional Fractionated External Multi-Field Irradiation up to 45 Gray. A Phase I/II Study |
| Lead sponsor | Technical University of Munich, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | cetuximab, fluorouracil, oxaliplatin, conventional surgery, neoadjuvant therapy, radiation therapy |
| Enrollment | 43 |
| Start date | Jul 1, 2006 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2015 |
| First posted | Jan 23, 2007 |
| Last update posted | May 1, 2014 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: